(Q37832687)

24 August 2017

1 reference

title

Serotonergic agents in the management of cluster headache (English)

1 reference

24 August 2017

1 reference

Giorgio Lambru

1

1 reference

24 August 2017

Manjit Matharu

series ordinal

2

1 reference

24 August 2017

language of work or name

English

0 references

publication date

1 April 2011

1 reference

Current Pain and Headache Reports

24 August 2017

published in

1 reference

24 August 2017

volume

15

1 reference

24 August 2017

issue

2

1 reference

24 August 2017

page(s)

108-117

1 reference

Sumatriptan inhibits synaptic transmission in the rat midbrain periaqueductal grey.

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11916-011-0176-4

Revisiting the role of ergots in the treatment of migraine and headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-011-0176-4

Serotonin and migraine: biology and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-011-0176-4

Serotonin depletion, cortical spreading depression, and trigeminal nociception

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-011-0176-4

Serotonin metabolism in cluster headache.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-011-0176-4

The m-chlorophenylpiperazine test in cluster headache: a study on central serotoninergic activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-011-0176-4

Abnormal 5-HT1D receptor function in cluster headache: a neuroendocrine study with sumatriptan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-011-0176-4

Ergotamine and dihydroergotamine: history, pharmacology, and efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-011-0176-4

Further characterization of the putative 5-HT receptor which mediates blockade of neurogenic plasma extravasation in rat dura mater

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-011-0176-4

Central activation of the trigeminovascular pathway in the cat is inhibited by dihydroergotamine. A c-Fos and electrophysiological study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-011-0176-4

A particular variety of headache.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-011-0176-4

Side effects of ergotamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-011-0176-4

Safety and pharmacokinetics of dihydroergotamine mesylate administered via a Novel (Tempo) inhaler

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-011-0176-4

The treatment of cluster headache with repetitive intravenous dihydroergotamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-011-0176-4

Outpatient intravenous dihydroergotamine for refractory cluster headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-011-0176-4

Evidence base for the medical treatments used in cluster headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-011-0176-4

Management of trigeminal autonomic cephalgias and hemicrania continua

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-011-0176-4

Fibrotic Disorders Associated with Methysergide Therapy for Headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-011-0176-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-011-0176-4

The association of the combination of sumatriptan and methysergide in myocardial infarction in a premenopausal woman

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-011-0176-4

Methylergonovine maleate as a cluster headache prophylactic: a study and review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-011-0176-4

21 January 2018

Ergot and its alkaloids

1 reference

https://api.crossref.org/works/10.1007%2FS11916-011-0176-4

The behavioral pharmacology of hallucinogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-011-0176-4

Response of cluster headache to psilocybin and LSD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-011-0176-4

The non-hallucinogen 2-bromo-lysergic acid diethylamide as preventative treatment for cluster headache: an open, non-randomized case series

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-011-0176-4

Treatment of Acute Cluster Headache with Sumatriptan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-011-0176-4

Cluster headache attacks treated for up to three months with subcutaneous sumatriptan (6 mg). Sumatriptan Cluster Headache Long-term Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-011-0176-4

Effectiveness of intranasal zolmitriptan in acute cluster headache: a randomized, placebo-controlled, double-blind crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-011-0176-4

Zolmitriptan nasal spray in the acute treatment of cluster headache: a double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-011-0176-4

Oral zolmitriptan is effective in the acute treatment of cluster headache.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-011-0176-4

Naratriptan prophylactic treatment in cluster headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-011-0176-4

Naratriptan in the preventive treatment of cluster headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-011-0176-4

Frovatriptan for the treatment of cluster headaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-011-0176-4

Intracellular pathways underlying the effects of lithium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-011-0176-4

Lithium in the treatment of chronic cluster headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-011-0176-4

Lithium for cluster headache: review of the literature and preliminary results of long-term treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-011-0176-4

Double-blind placebo-controlled trial of lithium in episodic cluster headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-011-0176-4

Sodium valproate induced alterations in monoamine levels in different regions of the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-011-0176-4

A negative trial of sodium valproate in cluster headache: methodological issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-011-0176-4

The role of 5-hydroxytryptamine (5-HT) receptor subtypes and plasticity in the 5-HT systems in the regulation of nociceptive sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-011-0176-4

The role of 5-HT1B and 5-HT1D receptors in the selective inhibitory effect of naratriptan on trigeminovascular neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-011-0176-4

Direct evidence for central sites of action of zolmitriptan (311C90): an autoradiographic study in cat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-011-0176-4

The 5-HT7 receptor and disorders of the nervous system: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-011-0176-4

Selective inhibition of 5-HT7 receptor reduces CGRP release in an experimental model for migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-011-0176-4

5-HT7 receptor-mediated dilatation in the middle meningeal artery of anesthetized rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-011-0176-4

5-HT7 receptor activation inhibits mechanical hypersensitivity secondary to capsaicin sensitization in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-011-0176-4

Is the 5-HT(7) receptor involved in the pathogenesis and prophylactic treatment of migraine?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-011-0176-4

Psychopharmacological studies of lysergic acid diethylamide (LSD-25) intoxication; effects of premedication with BOL-128 (2-bromo-d-lysergic acid diethylamide), mescaline, atropine, amobarbital, and chlorpromazine

21 January 2018

1 reference

12 December 2020

Aerosol ergotamine tartrate for migraine and Horton's syndrome

1 reference

12 December 2020

Subcutaneous sumatriptan in the acute treatment of cluster headache: a dose comparison study. The Sumatriptan Cluster Headache Study Group.

1 reference

12 December 2020

Effects of lithium chloride on parameters biosynthetic capacity for 5-hydroxytryptamin in rat brain

1 reference

12 December 2020

Response of Cluster Headache Attacks to Oxygen Inhalation

1 reference

12 December 2020

Prophylactic and therapeutic properties of 1-methyl-lysergic acid butanolamide in migraine

1 reference

12 December 2020

Prophylactic treatment of cluster headache with a new serotonin antagonist, BC 105

1 reference

12 December 2020

Acute therapy for cluster headache with sumatriptan: findings of a one-year long-term study

1 reference

12 December 2020

An antaminic drug, BC 105, in the prophylaxis of migraine. Pharmacological, clinical, and therapeutic experiences.

1 reference

12 December 2020

1 reference

12 December 2020

1 reference

12 December 2020

Concentration and uptake of 5-hydroxytryptamine in platelets from cluster headache and migraine patients

1 reference

12 December 2020

Differential effect of lithium on 5-HT1 receptor-linked system in regions of rat brain

1 reference

12 December 2020

Clinical observations on the use of E.C. 110, a new agent for the treatment of headache

1 reference

12 December 2020

Ergotamine tartrate inhalation: a new approach to the management of recurrent vascular headaches

1 reference

12 December 2020

Pizotifen (BC-105): a review of its pharmacological properties and its therapeutic efficacy in vascular headaches

1 reference

12 December 2020

Double blind comparison of lithium and verapamil in cluster headache prophylaxis

1 reference

12 December 2020

Structure and function of the brain serotonin system

1 reference

12 December 2020

PROPHYLACTIC TREATMENT OF MIGRAINE BY MEANS OF LYSERGIC ACID DERIVATIVES

1 reference

12 December 2020

Dihydroergotamine nasal spray in the treatment of attacks of cluster headache. A double-blind trial versus placebo

1 reference

12 December 2020

Treatment of headache with ergotamine-caffeine suppositories

1 reference

12 December 2020

10.1007/S11916-011-0176-4

Identifiers

DOI

1 reference

24 August 2017

1 reference